跳至主要内容
临床试验/CTRI/2024/06/068299
CTRI/2024/06/068299已完成3 期

Effect of low dose intrathecal morphine as a part of multimodal analgesia in patients undergoing cardiac surgeries through sternotomy – open-label randomized control trial.

All India Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2024年6月14日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
104
试验地点
1
主要终点
To assess postoperative pain by visual analogue scale (VAS) score

研究概览

简要总结

Title

Effect of low dose intrathecal morphine as a part of multimodal analgesia in patients undergoing cardiac surgeries through sternotomy - prospective randomized control trial

|Study center

All India Institute of Medical Sciences, Raipur, India

|Phase

Randomized Control Trial - Phase 3

|Methodology

Single-center, open-label randomized controlled trial

|Study duration

1.5 years

|Objectives

Primary:

To assess the quality of Analgesia based on VAS pain score in the postoperative period for 24 hours.

Secondary:

To assess the total opioid consumption with rescue analgesia and other associated complications.

|Number of subjects

104

|Main inclusion and exclusion criteria

Inclusion criteria:

· Patients of age 18 to 65 years undergoing midline sternotomy for cardiac surgeries.

· New York Heart Association grade II-III patients.

Exclusion criteria:

· Patient refusal. · Contraindication to intrathecal analgesia: infection at injection site, coagulopathy, allergy to morphine. · Pre-existing chronic pain: taking routine analgesics. · Patients with a history of chronic opiate abuse. · Patients with psychiatric disorders. · Patients with previous surgery in the thoracic vertebral region. · Preexisting neurological condition (spinal cord injury, multiple sclerosis, etc.). · Patients with BMI more than or equal to 35. · Patients with severe respiratory disease. · Those expected to be on elective mechanical ventilation for >6 hours postoperatively. · Patients with renal dysfunction (Serum creatinine > 1.5 mg/dl).

|Intervention

P

Population

Patients aged 18 to 65 years undergoing midline sternotomy for cardiac surgeries

|I

Intervention

Intrathecal morphine

|C

Control

Standard treatment

|O

Outcomes

Postoperative pain by visual analogue scale (VAS) score

|Outcomes

Primary outcome: To assess postoperative pain by visual analogue scale (VAS) score.Secondary outcome: 1. Total dose of opioids received in the postoperative period (at first 24 hours). 2. Time taken for the first dose of rescue analgesia. 3. To evaluate the incidence of any side effects: Respiratory depression, nausea,   and vomiting, pruritus, the incidence of reintubation, sedation

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients aged 18 to 65 years undergoing midline sternotomy for cardiac surgeries, New York Heart Association grade II-III patients.

排除标准

  • Patient refusal to consent, contraindications to intrathecal analgesia such as infection at the injection site, coagulopathy, and allergy to morphine, pre-existing chronic pain: taking routine analgesics, patients with a history of chronic opiate abuse, patients with psychiatric disorders, patients with previous surgery in thoracic vertebral region, preexisting neurological condition (spinal cord injury, multiple sclerosis, etc.), patients with BMI more than or equal to 35, patients with severe respiratory disease, those expected to be on elective mechanical ventilation for more than 6 hours postoperatively, patients with renal dysfunction (Serum creatinine more than 1.5 mg/dl).

结局指标

主要结局

To assess postoperative pain by visual analogue scale (VAS) score

时间窗: upto 24 hour post-operative period

次要结局

  • Total dose of opioids received in the postoperative period (at first 24 hour)(upto 24 hour post-operative period)
  • Time taken for the first dose of rescue analgesia(in first 24 hour post-operative period)
  • To evaluate the incidence of any side effects such as respiratory depression, nausea and vomiting, pruritus, incidence of reintubation and sedation(upto 24 hour post-operative period)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Anil Gupta

All India Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验